Section 807 of the FDA Reauthorization Act of 2017 (FDARA) requires the FDA to report on certain abbreviated new drug applications (ANDAs).
administrator
Related Articles
27th Meeting of the Society of Hair Testing…
- December 13, 2025
New Metabolites of Methyldienolone by In Vitro Human Liver…
- December 12, 2025
A First Report of the Misuse of a…
- December 12, 2025